These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 31975695)

  • 1. Assessment of liver and renal functions in human immunodeficiency virus-infected persons on highly active antiretroviral therapy: A mixed cohort study.
    Mahajan VK; Wadhwa D; Sharma A; Chauhan S; Vashist S; Kumar P; Chowdhry B
    Indian J Dermatol Venereol Leprol; 2020; 86(5):499-507. PubMed ID: 31975695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Highly Active Antiretroviral Therapy on Albuminuria in HIVinfected Persons.
    Adedeji TA; Adebisi SA; Adedeji NO
    Infect Disord Drug Targets; 2020; 20(3):374-384. PubMed ID: 31389318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Highly Active Antiretroviral Therapy on Renal Function and Renal Phosphate Handling in African Adults with Advanced HIV and CKD.
    Adedeji TA; Adebisi SA; Adedeji NO; Biliaminu SA; Olanrewaju TO
    Infect Disord Drug Targets; 2019; 19(1):88-100. PubMed ID: 30027856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatotoxicity from first line antiretroviral therapy: an experience from a resource limited setting.
    Kalyesubula R; Kagimu M; Opio KC; Kiguba R; Semitala CF; Schlech WF; Katabira ET
    Afr Health Sci; 2011 Mar; 11(1):16-23. PubMed ID: 21572852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiretroviral-associated toxicity among HIV-1-seropositive pregnant women in Mozambique receiving nevirapine-based regimens.
    Jamisse L; Balkus J; Hitti J; Gloyd S; Manuel R; Osman N; Djedje M; Farquhar C
    J Acquir Immune Defic Syndr; 2007 Apr; 44(4):371-6. PubMed ID: 17259905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HAART, DOTS and renal disease of patients co-infected with HIV/AIDS and TB in the South West Region of Cameroon.
    Nsagha DS; Pokam BT; Assob JC; Njunda AL; Kibu OD; Tanue EA; Ayima CW; Weledji PE
    BMC Public Health; 2015 Oct; 15():1040. PubMed ID: 26452646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors of severe hepatotoxicity among HIV-1 infected individuals initiated on highly active antiretroviral therapy in the Northwest Region of Cameroon.
    Abongwa LE; Nyamache AK; Charles F; Torimiro J; Emmanuel N; Domkam I; Eyongetah M; Jude B; Mua FH; Bella S; Tamboh TC; Moungang EC; Ngum V; Okemo P
    BMC Gastroenterol; 2022 Jun; 22(1):286. PubMed ID: 35658835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of liver fibrosis on highly active antiretroviral therapy-associated hepatotoxicity in patients with HIV and hepatitis C virus coinfection.
    Aranzabal L; Casado JL; Moya J; Quereda C; Diz S; Moreno A; Moreno L; Antela A; Perez-Elias MJ; Dronda F; Marín A; Hernandez-Ranz F; Moreno A; Moreno S
    Clin Infect Dis; 2005 Feb; 40(4):588-93. PubMed ID: 15712082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative Evaluation of Prevalence, Risk Factors, and Pathologic Features of Kidney Disease in Highly Active Antiretroviral Therapy-Naive and Highly Active Antiretroviral Therapy-Experienced Patients at a Tertiary Health Facility in Maiduguri, Northeastern Nigeria.
    Sulaiman MM; Shettima J; Ummate I; Arogundade FA; Yusuph H; Nwankwo E; Sanusi AA; Akinsola A
    Saudi J Kidney Dis Transpl; 2022; 33(1):72-79. PubMed ID: 36647981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective study of adverse events to antiretroviral therapy in HIV- infected adults in Ekiti State, Nigeria.
    Popoola TD; Awodele O; Oshikoya KA
    Afr J Med Med Sci; 2016 Jun; 45(2):179-187. PubMed ID: 29465861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver injury in HIV-1-infected patients receiving non-nucleosides reverse transcriptase inhibitors-based antiretroviral therapy.
    Li ZC; Li HJ; Dai LL; Gao YQ; Cai WP; Li HY; Huang XJ; Zhang T; Wu H
    Chin Med J (Engl); 2010 Dec; 123(24):3587-90. PubMed ID: 22166636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HBV, HCV, and HBV/HCV co-infection among HIV-positive patients in Hunan province, China: Regimen selection, hepatotoxicity, and antiretroviral therapy outcome.
    Su S; Fairley CK; Sasadeusz J; He J; Wei X; Zeng H; Jing J; Mao L; Chen X; Zhang L
    J Med Virol; 2018 Mar; 90(3):518-525. PubMed ID: 29091279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Highly active antiretroviral therapy-related hepatotoxicity in human immunodeficiency virus and hepatitis C virus co-infected patients with advanced liver fibrosis in Taiwan.
    Chou CC; Tsai HC; Wu KS; Sy CL; Chen JK; Chen YS; Lee SS
    J Microbiol Immunol Infect; 2016 Aug; 49(4):546-53. PubMed ID: 25440980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Administration of tenofovir disoproxil fumarate-based antiretroviral therapy in an HIV-infected patient following unilateral nephrectomy.
    Biagi M; Badowski M; Chiampas T; Young J; Vaughn P; Shicker L; Patel M
    Int J STD AIDS; 2016 Aug; 27(9):808-11. PubMed ID: 26378193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of low estimated glomerular filtration rate, proteinuria, and associated risk factors among HIV-infected black patients using Cockroft-Gault and modification of diet in renal disease study equations.
    Longo AL; Lepira FB; Sumaili EK; Makulo JR; Mukumbi H; Bukabau JB; Mokoli VM; Kayembe PK; Nseka NM
    J Acquir Immune Defic Syndr; 2012 Jan; 59(1):59-64. PubMed ID: 21926635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anemia and risk factors in HAART naïve and HAART experienced HIV positive persons in south west Ethiopia: a comparative study.
    Gedefaw L; Yemane T; Sahlemariam Z; Yilma D
    PLoS One; 2013; 8(8):e72202. PubMed ID: 23977253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The significance of antiretroviral-associated acute kidney injury in a cohort of ambulatory human immunodeficiency virus-infected patients.
    Wikman P; Safont P; Del Palacio M; Moreno A; Moreno S; Casado JL
    Nephrol Dial Transplant; 2013 Aug; 28(8):2073-81. PubMed ID: 23739150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal dysfunction among adult HIV/AIDS patients on antiretroviral therapy at a tertiary facility in Ghana.
    Obiri-Yeboah D; Awuku YA; Alofa W; Charwudzi A; Aniakwa-Bonsu E; Obboh E; Nsiah P
    BMC Nephrol; 2018 Nov; 19(1):333. PubMed ID: 30463531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective, open-label comparative study of liver toxicity in an unselected population of HIV-infected patients treated for the first time with efavirenz or nevirapine.
    Manfredi R; Calza L; Chiodo F
    HIV Clin Trials; 2005; 6(6):302-11. PubMed ID: 16452064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD4+ cell count, viral load, and highly active antiretroviral therapy use are independent predictors of body composition alterations in HIV-infected adults: a longitudinal study.
    McDermott AY; Terrin N; Wanke C; Skinner S; Tchetgen E; Shevitz AH
    Clin Infect Dis; 2005 Dec; 41(11):1662-70. PubMed ID: 16267741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.